F16.129

Clinical Causes: Intentional recreational use of hallucinogenic drugs such as LSD, psilocybin, or mescaline. Accidental ingestion or overdose of hallucinogen-containing substances. Use of contaminated or adulterated drugs with hallucinogenic properties. Misuse by individuals seeking to alter their mental state or escape reality.

Key Symptoms: Visual or auditory hallucinations, such as seeing or hearing things that aren't present. Altered perception of time, space, or reality. Euphoria, feelings of enlightenment, or spiritual experiences. Anxiety, paranoia, or panic attacks. Confusion, disorientation, or impaired judgment. Physical effects such as increased heart rate, dizziness, sweating, nausea, or tremors.

Diagnosis Path: Diagnosis typically involves a clinical assessment by a healthcare professional who evaluates the individual's history of substance use, current mental status, and physical symptoms. Laboratory tests, such as blood or urine screenings, may detect the presence of hallucinogenic substances. Since the ICD-10 code specifies 'unspecified,' detailed diagnosis hinges on recognizing the signs of intoxication and confirming recent substance use, while considering other potential causes for symptoms.

Treatment Protocols: Treatment approaches focus on managing symptoms and addressing any underlying issues related to substance misuse. Immediate care may include monitoring vital signs, providing a safe environment, and supporting mental health. Long-term strategies involve counseling, behavioral therapy, and programs aimed at substance abuse prevention and recovery. In severe cases, hospitalization may be necessary to ensure safety and provide specialized care. Prevention efforts emphasize education about the risks of hallucinogen misuse and promoting healthier coping mechanisms.